ArticleInternational journal of nephrology2026
Prognostic Value of Standard Base Excess in Sepsis-Associated Acute Kidney Injury: A Retrospective Cohort Study.
Article in International journal of nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Standard base excess (SBE) is a pivotal indicator of metabolic acid-base status and has been associated with adverse outcomes in critically ill patients. Nevertheless, the evidence regarding its association with mortality risk in sepsis-associated acute kidney injury (SA-AKI) remains limited. Methods: The present study utilized the MIMIC-IV database and comprised 16,842 adult patients with SA-AKI. Patients were stratified into quartiles based on SBE levels. The association between SBE and 28-day and 180-day all-cause mortality was evaluated using Cox proportional hazards models. Restricted cubic spline analysis was performed to assess potential nonlinear relationships. Multivariable adjustments and subgroup analyses were conducted to ensure the robustness of the findings. Results: Multivariate Cox regression analysis demonstrated that patients in the higher SBE quartiles had significantly lower risks of 28-day and 180-day mortality compared to those in the lowest quartile. Kaplan-Meier survival curves and restricted cubic spline analysis further confirmed a significant association between SBE levels and mortality risk, with evidence of a nonlinear relationship. Subgroup analyses showed different interaction effects between the primary and secondary outcomes. Conclusions: SBE was associated with mortality risk in patients with SA-AKI, with lower levels of SBE being associated with worse outcomes. As a routine blood gas parameter, SBE may serve as a useful indicator for risk stratification and prognostic assessment in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.